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Abstract: The incidence of venous extension to the inferior vena cava (IVC) in renal cell carcinoma (RCC) is markedly 
increased recently mostly due to the advances in diagnostic modalities. Such vascular invasion implies a heightened biologic 
behavior and a surgical challenge during the course of treatment. In this study, we reviewed the classiﬁ  cation guidelines, 
recent diagnostic tools and up-to-date therapeutic modalities for RCC with IVC tumor thrombi added to the prognostic 
signiﬁ  cance regarding the pathologic nature of vascular invasion; cephalad extent of thrombi and any associated distant 
metastasis. Also, we are providing our suggestion regarding the use of angioscopy for removal of IVC thrombi in a relatively 
bloodless ﬁ  eld without aggressive surgical manipulations or shunt techniques for maintenance of hemodynamic stability.
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Introduction
Venous migration and tumor thrombus formation are unique aspects of renal cell carcinoma (RCC)
1 
with signiﬁ  cant therapeutic and prognostic implications.
2 It has been reported to occur in 4%–10% of 
patients with renal neoplasms.
3 Within this group, 2%–16% have tumors extending into the right atrium.
4 
The tumor thrombus may invade the caval wall which is difﬁ  cult, if not impossible, to predict preop-
eratively.
1 In this study; the classiﬁ  cation, recent diagnostic tools and therapeutic modalities for the IVC 
thrombi in patients with RCC are reviewed. Also, controversial studies regarding the prognostic sig-
niﬁ  cance of such thrombi and their cephalad extent in the venous system will be discussed. Finally, a 
new technique regarding the use of angioscopy for removal of caval thrombi under direct vision is 
highlighted for future studying.
Classiﬁ  cation
The traditional classiﬁ  cation of RCC caval thrombi is as follows (Fig.1)
3:
Group I: Venous thrombus in the renal vein not reaching IVC.
Group II: Infra-hepatic IVC thrombus.
Group III:   Thrombi in retrohepatic or suprahepatic IVC not reaching the right atrium. Because of the 
prognostic relevance of the cranial intracaval neoplastic extension and the surgical conse-
quences related to IVC exposure as well as the degree of vascular control required to extract 
these thrombi,
5 group III is further subdivided according to the anatomical relation of the 
thrombus to the major hepatic veins
6:-
  IIIa   (intrahepatic): A thrombus extending into the retrohepatic IVC but below the ostia of 
major hepatic veins.
  IIIb  (hepatic): A thrombus extending into the retrohepatic IVC reaching the ostia of the major 
hepatic veins and may extend into them causing Budd-Chiari syndrome.
  IIIc   (suprahepatic, infradiaphragmatic): A thrombus extending into the retrohepatic IVC 
above the major hepatic veins but below the diaphragm.
 IIId    (suprahepatic, supradiaphragmatic and infra-atrial): A thrombus extending into the 
supradiaphragmatic, intrapericardial IVC but not into right Atrium.
Group IV: Right atrial thrombi.248
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Diagnosis
The progressively rising incidence of RCC has, in 
part, been attributed to early detection of tumors by 
the widespread use of abdominal imaging modali-
ties as ultrasound, computed tomography (CT) and 
magnetic resonance imaging (MRI).
7 The overall 
goal of preoperative imaging is to determine the 
malignant potential of the lesion, assess tumor size 
and location, determine capsular invasion, and 
identify regional lymphadenopathy or metastases 
for accurate staging. In addition, the renal vein and 
IVC need to be assessed for tumor thrombi.
8
Traditionally, venacavography was the gold 
standard for detection of tumor thrombi (Fig. 2-C).
9 
However, it is rarely used recently as it is not able 
to demonstrate caval wall invasion by the neoplas-
tic process and is not additive to ultrasonography, 
CT, and MRI added to its associated high risk of 
contrast-induced renal injury.
4
Ultrasound is the ﬁ  rst imaging modality used 
to evaluate patients with RCC. However, its sen-
sitivity in detecting tumor thrombi depends on the 
position of the thrombus with a lower sensitivity 
for infrahepatic than for intrahepatic thrombi (68% 
and 100% respectively).
10
CT is extremely useful in demonstrating the 
cephalad extent of the thrombus and occult metas-
tasis in the majority of cases (Fig. 2-A&B).
4 
Level-I    Level-II  Level-III   Level-IV
III-a
Intrahepatic
III-b
Hepatic
III-c
Suprahepatic
III-d
Supradiaphragmatic
Figure 1. Classiﬁ  cation of RCC with IVC thrombi showing the sub-divisions of group-III thrombi.249
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Venous extension is optimally visualized during 
the corticomedullary phase of enhancement, when 
contrast enhancement of the renal vein is at its 
peak, as a low density-ﬁ  lling defect within the 
vein. Enhancement pattern of thrombi helps to 
distinguish tumor thrombi from bland ones. How-
ever, conventional CT has a lower sensitivity in 
delineating the superior margin of the thrombus 
when compared to MRI (76% and 100% respec-
tively). The evolution of multidetector (MS) CT; 
which provides a three-dimensional rotational CT 
image, improved CT sensitivity in RCC (up to 
95%)
11 by accurately demonstrating the relation-
ship of the renal mass with the renal tissue and 
adjacent organs and vessels and facilitating detec-
tion of tumor thrombi and distant metastases 
hence accurate staging and operative planning.
12 
The drawbacks of MS CT include (1) renal vein 
tapering and failure of visualization of tumor 
thrombi due to failure of contrast medium 
inﬂ  ow to the IVC in the presence of an extensive 
tumor thrombus or by an external renal vein or 
A B
C
Figure 2. A: Abdominal CT showing Rt. RCC (white arrow) with a large tumor thrombus extending into the IVC (black arrow). B: Abdominal 
CT for the same patient’s Rt. kidney (Upper pole) with a large tumor thrombus extending more cephalad in the IVC (black arrow). C: Vena-
cavography (for the same patient) showing dilated IVC collaterals due to a large tumor thrombus extending into the IVC (white arrows) up 
to right atrium (black arrows).250
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caval compression by an adjacent metastatic 
tumor or enlarged lymph nodes and (2) failure to 
precisely delineate the cephalad extent of the 
thrombus as blood and thrombus radiological 
densities can be similar.
10
Currently, MRI is the gold standard for delin-
eating the level and extent of tumor thrombi in the 
IVC and staging of RCC with a sensitivity of 
96–100% and it may rule out caval wall invasion 
so the exact surgical procedure can be planned.
13,14 
It is proved to be superior to MS CT for thrombus 
detection, delineating its cephalad level and 
staging of RCC because of its ability to have a 
free imaging plane with an optimal spatial 
resolution in the sagittal and coronal planes.
14 
Also, it has intrinsic contrast superiority to CT and 
does not need to rely on contrast medium to 
differentiate tumor thrombus from blood. However, 
recent studies showed that MRI diagnosis of 
a tumor thrombus is not signiﬁ  cantly better than 
that of MS CT.
13
The diagnostic effect of Positron Emission 
Tomography (PET) is dependant on the abnormal 
uptake of 18-ﬂ  uoro-2-deoxyglucose (FDG) by the 
tumor tissues and its hypermetabolic thrombi with 
a sensitivity of 77%–94% in RCC.
15 The draw-
backs of PET in RCC include: (1) FDG is renally 
excreted without signiﬁ  cant tubular reabsorption. 
This mode of excretion results in collecting system 
accumulation and makes the identification of 
parenchymal lesions more difﬁ  cult. Most primary 
renal tumors have moderate but variable uptake 
of 18F-FDG when compared with metastatic 
lesions.
16 (2) its ability to demonstrate modest 
FDG uptake in granulation tissues and inﬂ  amma-
tory venous processes including catheter-induced 
thrombi and septic thrombophlebitis that may be 
misinterpreted as malignancy.
15,17 So, positive 
PET venous ﬁ  ndings require correlation with the 
clinical history and supplemental cross-sectional 
imaging to determine the exact nature of the 
thrombus for adequate therapy. Recent studies 
reported the signiﬁ  cance of using a combined 
PET-CT imaging system to gain the diagnostic 
beneﬁ  ts of both investigative techniques in ana-
tomic localization and deﬁ  nition of RCC and the 
level and pathologic nature of any associated IVC 
thrombi which may be equivalent to or more sen-
sitive than MRI.
17
Duplex scanning and trans-esophageal echocar-
diography can be performed pre- and intraopera-
tively to conﬁ  rm the cephalad extent of tumor 
thrombus and to evaluate cardiac function 
especially for level IIId and IV thrombi.
18
Surgical Principles
Surgical objectives: (1) Complete resection of 
tumor and its caval thrombi, (2) prevention of 
tumor embolism by temporary placement of an 
IVC ﬁ  lter or plication of the IVC in its suprahepatic 
or retrohepatic segment,
18 (3) minimizing blood 
loss, (4) maintenance of hemodynamic stability, 
and (5) prevention of vital organ ischemia.
Incision and retraction: for infrahepatic and 
intrahepatic IVC thrombi, a midline transperitoneal 
incision provides a generous access to the IVC. 
Bilateral subcostal approaches have also been used 
for equivalent exposure.
8 As the thrombus level 
migrates cephalad, a thoraco-abdominal approach 
is warranted which entails a triradiate incision 
including two subcostal incisions extending out 
lateral to the mid axillary line and a vertical midline 
incision up to the xiphoid process. A self-retaining 
retractor is placed to elevate the costal margins and 
splay them laterally toward the axillae which helps 
to ﬂ  atten the diaphragm and enables easier liver 
mobilization and access to the retrohepatic space 
in cases with thrombi extending in the suprahepatic 
IVC. In group IIId and IV thrombi; the diaphragm 
is cut in the midline at the IVC hiatus then the 
pericardium is opened to visualize the intrapericar-
dial IVC and the right atrium. The implementation 
of this minimal access versus a thoracic approach 
avoids the traditional midline sternotomy and has 
been paramount in reducing surgical morbidity.
8
Vascular control: After removal of the affected 
kidney, careful ligation of IVC lumbar tributaries 
that tether it to the posterior abdominal wall is 
mandatory to achieve circumferential vascular 
control of IVC.
19 Additionally; this maneuver 
allows liver rotation under IVC, thus, enabling 
exploration of the hepatic ostia end-on for any 
thrombus extension. However, it markedly reduces 
the venous return causing profound hypotension. 
Hemodynamic stability is restored by: (1) creating 
a veno-venous bypass in which IVC distal to the 
thrombus is cannulated with inﬂ  ow at the level of 
the right atrium or cephalic vein.
20 With a more 
cephalad extent of tumor thrombi, a pump-driven 
veno-venous bypass (VVB) can be done in which 
the IVC and the inferior mesenteric vein (for por-
tal decompression) are connected to the right 
atrium (Fig.3).
21 This technique allows a prolonged 251
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caval cross-clamping without affecting the 
hemodynamic status and avoids the surgical con-
sequences of cardiopulmonary bypass (CPB) 
techniques. (2) Concomitant partial or total cross-
clamping of the abdominal aorta. This technique 
will maintain systemic blood pressure above 
100 mmHg.
18 The infrarenal or the supracoeliac 
segments of abdominal aorta can be clamped. 
However, the later should not be continued for 
more than 30 minutes to avoid renal dysfunction 
of an only functioning kidney. (3) CPB with or 
without deep hypothermic circulatory arrest 
(DHCA) is used to maintain hemodynamic stability 
especially for level IIId and IV tumor thrombi.
Extraction of tumor thrombi: Further surgical 
approach is dependant on the cephalad extent of 
the tumor thrombus within the IVC.
Group I and II
Subhepatic thrombi can be easily removed during 
radical nephrectomy through a cavotomy. How-
ever, if the tumor directly invades the caval wall 
or the thrombus is large, adherent and chronically 
obstructing the caval lumen, resection and primary 
reconstruction of infrahepatic IVC can be done 
with minimal postoperative morbidity using 
autologous (venous or pericardial) or synthetic 
(e.g. polytetrafluoroethylene (PTFE) grafts 
(Fig. 4-A).
6 Prosthetic grafts are associated with a 
higher risk of thrombosis and infection.
Recent studies reported the possibility of excis-
ing a circumferential portion of infrahepatic IVC 
without reconstruction causing no morbidity or 
mortality directly related to surgery depending on 
an adequate collateral circulation.
1,18 The major 
concern is the venous drainage of the remaining 
kidney. For the left renal vein, it can be ligated 
without reconstruction (Fig. 4-D) depending on its 
rich collateral circulation (adrenal, gonadal and 
lumbar veins) which can be accurately assessed 
intraoperatively by measuring its stump pressure 
(an adequate collateral circulation is associa-
ted with a stump pressure 50–60 cm.water 
(37–44 mmHg) but a higher pressure carries the 
risk of renal congestion or rupture). However, it is 
not the case for the right renal vein which lacks 
adequate collaterals and should be anastomosed 
end-to-end to the distal IVC segment (Fig. 4-B&C) 
or to the portal vein (if the distal IVC stump is 
short).
18 Alternatively, a synthetic PTFE graft is 
used for anastomosis.
18
Group III
This group of caval thrombi poses a challenge to 
the surgeon due to its relative inaccessibility as the 
surgeon can not directly visualize the involved part 
of IVC.
6 So, hepatic mobilization using liver trans-
plantation (piggyback) technique is done to allow 
adequate exposure of the retrohepatic IVC.
1 The 
hepatic ligaments are divided including the liga-
mentum teres, falciform ligament and the left tri-
angular ligament. The visceral peritoneum is 
double-ligated and divided just below the inferior 
edge of the liver. Simultaneously the liver is gently 
rotated to the left, which helps to tent the right 
superior coronary ligament which is incised to 
rotate the liver to the midline, gradually exposing 
the retrohepatic IVC. Direct branches from the 
caudate lobe to the IVC should be carefully ligated 
so that the liver is attached to IVC only by the 
major hepatic veins and the retrohepatic IVC is 
completely visualized.
This maneuver will be sufﬁ  cient for extracting 
group IIIa thrombi. For more cephalad levels of 
group III thrombi; the cephalic IVC clamp should 
Figure 3. Diagrammatic illustration for the pump-driven veno-venous 
bypass (VVB) technique.
Abbreviations: RA: Right Atrium; IMV: Inferior mesenteric vein; RV: 
Renal vein.252
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be placed above the ostia of major hepatic veins 
which should be controlled by the Pringle’s maneu-
ver i.e. application of a soft-bladed occlusive clamp 
across the porta hepatis.
1 This will further impair 
the venous return and cause hepatic ischemia with 
consequent accumulation of toxic metabolites in 
the gut. However, it was reported that the tolerable 
normothermic continuous hepatic ischemic time 
is up to 15–30 minutes.
23 Then tumor thrombi are 
extracted after creating a veno-venous bypass or 
CPB technique as previously described.
Ciancio et al. described a successful technique 
in removing these thrombi without intraoperative 
bypass maneuvers depending on milking of the 
tumor thrombus below the level of the major 
hepatic veins which is facilitated by IVC dissection 
from the posterior abdominal wall, thus allowing 
the surgeon fingers to wrap circumferentially 
around the IVC and avoiding letting loose a throm-
bus fragment (Fig. 5).
6 This maneuver also helps 
in cases of Budd-Chiari syndrome as the resultant 
release of the congested liver is completely 
A
B C  D 
Figure 4. Options of resection of an invaded segment of subhepatic IVC. (A) Segment resection with reconstruction using PTFE graft. 
(B,C&D) Diagrammatic illustrations showing end-to-side right reno-caval anastomosis for left RCC (B), end-to-end left reno-caval anasto-
mosis for right RCC (C) and IVC resection without reconstruction in case of the left renal vein due to abundant collaterals (D).253
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intravascular. However, if the thrombus is adherent 
to the caval wall or if IVC is left tethered to the 
abdominal wall, milking will exert traction on the 
IVC and may cause tearing of the caval wall which 
is a disastrous consequence. In such cases; it is 
safer to perform veno-venous bypass as IVC may 
require reconstruction.
Group IV
In this group of tumor thrombi, the previous tech-
nique for group III thrombi is used added to CPB 
with or without DHCA to open the right atrium 
for extracting the tumor thrombus in a relatively 
bloodless ﬁ  eld.
4,18 Although these techniques are 
associated with signiﬁ  cant perioperative morbidity 
and mortality due to the associated postoperative 
coagulopathy from full heparinization in CPB and 
neurological sequelae from DHCA, they are time 
tested and have proved useful but they should be 
used with caution.
6 Modine et al. recently 
described a simpliﬁ  ed minimally invasive tech-
nique for CPB in which the ascending aorta was 
canulated and the venous drainage was achieved 
using a proximal canula inserted in the superior 
vena cava and a distal canula inserted in the infra-
renal IVC. Right atrial thrombus was extracted 
under normothermic CPB without cross clamping 
(just a temporary endoluminal occlusion catheter 
was introduced) or cardioplegic arrest.
24
Prognosis
The prognosis of RCC with IVC tumor thrombi is 
difﬁ  cult to predict due to a wide variety in clinical 
behavior.
25 Although involvement of the IVC in 
renal cancer is generally not a vascular invasion by 
the neoplastic process but mostly an intraluminal 
extension of the tumor mass, such intravascular 
growth implies a heightened biologic behavior of 
the tumor. Previous reports have shown that total 
resection of tumor affords the best chance of cure 
and long-term survival when no distant metastases 
are present.
4 Due to the absence of effective alterna-
tive treatment, recent reports recommend surgical 
treatment even in the presence of distant metasta-
ses.
26 With the advances in immunotherapy, sur-
vival of these patients may increase if aggressive 
surgery is combined with immunotherapy.
18,27
The prognostic signiﬁ  cance of IVC thrombi in 
RCC patients is still controversial. Furthermore, 
factors predicting the postoperative prognosis of 
RCC involving the IVC have not been well char-
acterized.
28 Numerous contemporary studies have 
demonstrated that tumor thrombus has a limited 
prognostic role in the absence of nodal and/or 
metastatic disease and that about 45%–70% of 
cases can be cured with surgical extirpation.
2,8 
Others showed that the prognosis of RCC with IVC 
thrombi is generally poor with 5-year survival rates 
about 25%–57%., despite surgical resection of 
RCC and tumor thrombus.
2,29
ABC
Figure 5. Diagrammatic illustration of steps of milking of IVC tumor thrombi below the level of major hepatic veins.254
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Various centers have reported mortality rates of 
2.7%–13% for IVC extension of RCC.
30 The major 
cause are of deaths reported to be pulmonary 
embolism and myocardial infarction or due to 
complications related to the bypass procedures. 
However, with better perioperative management 
and standardization of the surgical techniques, the 
mortality rates can be decreased considerably.
4
There is a controversy concerning the prognos-
tic signiﬁ  cance of the tumor thrombus level in the 
IVC.
31 Some studies suggest that the risks of 
metastases and early death increase with a more 
cephalad extent of IVC thrombi.
32 Skinner reported 
a 5-year survival rate of 35% after surgical treat-
ment for patients with RCC and a subhepatic IVC 
thrombus, 18% for those with intrahepatic, and 0% 
for those with atrial tumor thrombi.
32 Others found 
that in the absence of other adverse prognostic 
factors, the cephalad extension of IVC involvement 
is not prognostically important.
25,33
It has been shown that the patients with RCC 
extending only into the IVC have signiﬁ  cantly 
better survival rates than those with local spread 
of the tumor to the lymph nodes or perinephric 
tissue.
4 However, whether the perinephric spread 
is the only factor to affect the prognosis adversely 
in patients with RCC with IVC extension or not is 
controversial.
34 Libertino reported that perinephric 
spread, per se, does not affect the survival in 
patients with IVC thrombus.
34 In contrast, others 
have reported that, the presence of perinephric 
spread in RCC is a strong poor prognostic 
parameter.
16 In addition, there is also controversy 
concerning the prognostic signiﬁ  cance of distant 
metastasis in patients with RCC and IVC thrombus. 
Although the presence of distant metastasis is 
generally regarded as a poor prognostic indicator 
in patients with RCC involving the IVC, there was 
no significant difference in survival between 
patients with and without distant metastasis in 
some studies.
35
Patients with incomplete resections (excluding 
patients with metastatic disease) have a signiﬁ  cantly 
worse prognosis, a ﬁ  nding that reﬂ  ects the impor-
tance of surgical eradication of disease.
4 Hatcher 
noted that the prognosis was determined by the 
ability to perform a complete resection of the tumor, 
not by the level of tumor thrombus.
36,37
In conclusion, all patients with RCC and IVC 
tumor thrombi (even those with distant metastasis) 
should be considered for operation (as there is no 
other therapeutic modality). These tumors can be 
totally resected by an aggressive approach with an 
acceptable morbidity and mortality, and satisfac-
tory long-term survival rates.
25
Comments and Future Perspectives
Removal of IVC tumor thrombi during radical 
or cytoreductive nephrectomy implicates an 
aggressive surgical technique that may increase 
the operative morbidity and mortality. In addition 
to the previously mentioned hazards of different 
techniques, the possibility of missed tumor 
thrombi during these maneuvers is obvious mostly 
because removal of the tumor thrombus under 
direct vision necessitates cavotomy which may be 
so long with more cephalad extension of the 
thrombus.
As an imaging modality, angioscopy provides 
a simple method for the careful evaluation and 
treatment of the lumen of native vessels and 
bypass grafts. With the recent advance in 
endovascular tools, angioscopically guided 
luminal intervention has become an increasingly 
useful approach to many vascular problems.
38 The 
Angio-catheter can be used safely and successfully 
to remove thrombus from the native coronary 
artery of patients with myocardial infarction 
by rheolytic mechanisms.
39 To date, no studies 
were evolved reporting the possibility of a 
therapeutic role for vascular endoscopy in IVC 
tumor thrombectomy.
We hereby represent a suggestion about 
angioscopic removal of such tumor thrombi under 
direct vision. Preoperatively, a vascular ﬁ  lter is 
percutaneously inserted just above the cephalic end 
of the tumor thrombus (up to the pulmonary artery 
in right atrial thrombi) to prevent thrombus 
embolization during the maneuver. After removal 
of the affected kidney, a short segment of the 
abdominal IVC is dissected free from the posterior 
abdominal wall (to facilitate complete cross 
clamping after collecting the tumor thrombi in the 
infra-hepatic IVC). The renal vein stump on the 
affected side is secured by a non-crushing vascular 
clip (to be used as an entry for the angioscopic 
port). An occlusive multi-channel balloon catheter 
is percutaneously introduced from the femoral vein 
up to the infra-renal IVC and a similar catheter is 
introduced from the internal jugular vein passing 
the SVC (superior vena cava) and the right atrium 
to be inﬂ  ated in the upper end of the IVC. Both 
catheters are connected to a cell-salvage pump to 255
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which the distal catheter (venous limb) provides 
blood from both the infra- and supra-renal segments 
of IVC and the proximal catheter (inﬂ  ow limb) 
returns a puriﬁ  ed temperature-adjusted blood to 
the right atrium. By activation of this occlusive 
cell-salvaging veno-venous bypass system, the 
tumor thrombus bearing segment of IVC is 
completely occluded (except for a minimal ﬂ  ow 
from the major hepatic veins to allow better 
visualization of the caval wall and facilitates 
thrombectomy) without affecting the patient’s 
hemodynamics and without interrupting the hepatic 
vascular supply during the maneuver. The 
angioscope (larger than that used for coronary 
artery angioscopy) is introduced through a short   
port ﬁ  xed in the stump of the renal vein or in a very 
small cavotomy (to allow re-introduction of the 
angioscope without back bleeding). The angioscope 
is advanced into the IVC to detect the level of the 
thrombus, its pathologic nature and the degree of 
caval wall involvement (whether it is just extending 
into the caval lumen, adherent or inﬁ  ltrating the 
caval wall). If the thrombus is ﬂ  oating in the caval 
lumen or loosely adherent to the caval wall, it is 
gently sucked by a suction tube within the 
angioscope or dragged back to the abdominal IVC 
using a forceps or a multi-wired net basket. If the 
thrombus is inﬁ  ltrating the caval wall, gentle trials 
to dissect it should be done then the thrombus is 
dragged back to the abdominal IVC. But, if these 
trials failed, exploration and resection of the vena 
cava with or without reconstruction is considered 
according to the level of caval involvement. The 
ostia of the major hepatic veins are inspected for 
any possible thrombus extension which can be 
removed concomitantly. The IVC lumen is then 
inspected for any residual thrombi (which can be 
collected and distally dragged). A suprarenal IVC 
clamp is now applied above the thrombi. Attempts 
are made to remove the thrombi through the port 
opening using a suction irrigation technique 
through the angio-catheter. But if the thrombus is 
large, it can be removed through a small cavotomy. 
The port is then removed, the bypass system is 
deactivated and renal vein stump (or the abdominal 
IVC cavotomy) is secured.
If the thrombus extends into the right atrium, 
the patient is shifted to a transient hypotensive state 
and the atrial thrombus is removed by the angio-
scope by the same technique of caval thrombi (the 
angioscope can be guided by an esophageal echo-
cardiography if visualization in the right atrium is 
difﬁ  cult or hypotensive state is not preferred). 
Otherwise, it should be removed through an 
atriotomy using the simpliﬁ  ed CPB technique 
previously described.
24
This endoscopic removal of the tumor thrombi 
provides many advantages. At ﬁ  rst, it allows direct 
visualization of the tumor thrombi and the caval 
lumen through out the technique which is not 
accessible in open surgical techniques. Second, it 
avoids the aggressive time-consuming dissection 
of IVC from the posterior abdominal wall and liver 
mobilization with their surgical consequences 
including defragmentation of tumor thrombi dur-
ing the maneuver and the risk of postoperative 
renal or hepatic dysfunction. Third, it allows 
removal of thrombi in a relatively bloodless ﬁ  eld. 
Fourth, it provides a reduction in incision length 
and soft-tissue dissection which can result in 
decreased patient morbidity and extended patient 
beneﬁ  t also it can be done by a subcostal abdom-
inal approach or after performing hand-assisted 
laparoscopic nephrectomy (only the abdominal 
IVC is needed to be accessed). Fifth, it avoids the 
complicated techniques and the surgical conse-
quences of CPB and DHCA. In conclusion, man-
agement strategies for IVC thrombi in patients 
with RCC should be further studied to avoid major 
surgical trauma in such surgically compromised 
patients.
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